
Justice is not simply about outcomes—it is about perception. When the public perceives a ruling as inadequate, the legitimacy of the system fractures.
The terrorism charges are gone. What remains against Luigi Mangione is second-degree murder and associated weapons counts. The prosecution may still wrangle over evidence—his writings, the bullets inscribed with corporate jargon, the items in his backpack—but the case has been “streamlined.”
The likely verdict is clear: Mangione will be convicted of murder. Not terrorism. Not symbolic violence. Just murder.
Judge Carro made the boundary explicit:
“Unlike the Empire State Building or Brooklyn Bridge cases, which targeted groups with geopolitical or antisemitic intent, this case involved one individual.”
That line, narrow though it is, may determine everything. Justice is not simply about outcomes—it is about perception. When the public perceives a ruling as inadequate, the legitimacy of the system fractures.
• O.J. Simpson’s acquittal fractured trust in the justice system along racial and cultural lines.
• Mangione’s likely conviction—but absence of a terrorism label—may fracture trust along corporate and populist lines.
Both cases illustrate the architecture of justice: statutes, precedents, and juries built to contain human conflict. Both show its fragility when law lags perception.
In 1995, O.J. was acquitted of murder despite mountains of circumstantial evidence. The verdict revealed not only a legal gap but a cultural one: distrust of police, systemic racism, celebrity power.
Robert Kardashian’s role was pivotal—not legally, but narratively. He gave credibility to O.J.’s story. He blurred loyalty and legality, turning a trial into theater.
In Mangione’s case, the courtroom theater is subtler. Defense lawyers cast him as an angry man, not a terrorist. Prosecutors failed to scale his crime to the level of systemic fear. The judge played arbiter, keeping the narrative within narrow legal rails.
Yet the public may feel the outcome misses the point—that violence against corporate titans is inherently symbolic, inherently systemic. The law says no. The public may say yes.
The Mangione verdict will reveal how law remains reactive, not proactive. Terrorism statutes are tied to past horrors: 9/11, Oklahoma City, Brooklyn Bridge. They are written for organized networks, not lone wolves with AI-era grievances.
But the next wave of cases may not be lone wolves at all—they may be AI-assisted actors, radicalized online, operating with digital coordination invisible to current statutes.
If law cannot evolve, each verdict will feel like a bandage on a wound that keeps reopening. A guilty verdict for murder will satisfy statute but not sentiment. To the angry, it will look like the law refused to call corporate violence what it is. To investors, it will look like CEOs are vulnerable symbols with no systemic protection. To global observers, it will look like America has chosen to protect corporations as legal persons but not as cultural ones. The verdict matters less for Mangione than for the systemic lessons it fails to teach.
The architecture of justice in America is creaking. O.J. showed us that law cannot contain celebrity and race. Mangione shows us that law cannot contain corporate rage and symbolic violence. Both trials reveal the same truth: the courtroom may deliver a verdict, but the court of public opinion decides legitimacy.
The likely outcome is straightforward: Mangione guilty of murder. But the deeper outcome is unsettling: a justice system increasingly unable to address the complexities of modern violence, AI radicalization, and corporate symbolism.
Because in the end, the question is not whether Mangione will be convicted. The question is whether America’s legal architecture can survive the next O.J.—or the next Mangione—without collapsing under the weight of perception.

For most of aviation history, human flight has required an aircraft: a machine large enough to generate lift, carry fuel, accommodate passengers, and surround its occupants with an engineered structure. Emerging personal-flight technologies are beginning to loosen that relationship. Jet suits, powered wings, compact electric vertical-lift systems, autonomous drones, and increasingly sophisticated flight-control technologies suggest that aviation may eventually encompass machines worn, mounted, or summoned rather than conventionally boarded. The viral spectacle is irresistible. A person rises from the ground, accelerates over water, and appears to have acquired a superpower. Yet spectacle obscures the engineering. Human-scale powered flight confronts brutal constraints involving energy density, heat, noise, stability, endurance, payload, weather, redundancy, training, regulation, and the consequences of mechanical failure. A technology can fly successfully and still be unsuitable for mass transportation. That distinction is central to understanding personal aviation. The most plausible near-term applications are unlikely to involve commuters casually flying between homes and offices. Specialist environments — emergency response, defence, offshore infrastructure, inaccessible terrain, inspection, rescue, and certain industrial operations — provide a more credible pathway because the economic value of reaching somewhere quickly can outweigh the technology’s considerable limitations. The deeper development, however, extends beyond jet suits. Aviation is becoming computational. Sensors can stabilise machines faster than human reflexes. Software can continuously adjust thrust. Lightweight materials reduce mass. Autonomous navigation increasingly separates piloting from constant manual control. Electric propulsion enables aircraft configurations that would have been impractical under traditional mechanical architectures. The result is not necessarily the death of the aeroplane. Commercial aircraft remain extraordinarily efficient at moving large numbers of people over long distances. Instead, aviation may be fragmenting into a richer ecosystem: aircraft for distance, drones for autonomous logistics, eVTOL systems for specialised regional movement, and wearable or highly compact systems for particular human-scale missions. The important question is therefore no longer simply, “Can a person fly without an aeroplane?” We already know that certain machines can make that possible. The better question is: when does removing the aircraft make flight more useful?

Canada’s Medical Assistance in Dying programme has moved an ancient human question into modern medicine: when suffering becomes intolerable, who should have authority over how life ends? In 2024, 16,499 people received MAID—5.1 per cent of deaths in Canada. Yet the headline conceals crucial distinctions: 95.6 per cent were people whose natural deaths were reasonably foreseeable; 4.4 per cent were not. Most recipients had received palliative care, while disability advocates, clinicians, ethicists and policymakers continue to dispute whether safeguards can adequately separate autonomous choice from suffering intensified by inadequate social support. The future makes the question harder. Medicine is simultaneously extending life, managing once-fatal disease, expanding organ transplantation and developing technologies that could prolong healthy longevity. A civilisation capable of keeping people alive for longer must therefore become equally sophisticated about what makes continued life worth living. The central question is larger than MAID: can a society protect the right to choose death without allowing failures of care to narrow the possibility of choosing life?

For four decades, the central challenge of HIV medicine has been control. Antiretroviral therapy can suppress the virus so effectively that people living with HIV can lead long, healthy lives and, when viral load remains undetectable, do not transmit HIV sexually. Yet treatment does not remove the latent viral reservoir embedded within the body, meaning therapy usually must continue. A developing body of HIV research is asking a different question: rather than continually suppressing an active virus, could medicine make its hidden genetic machinery remain silent? A 2025 Science Advances study found that an HIV-derived antisense transcript known as AST could reinforce viral latency in cells from people receiving treatment. Subsequent research confirmed that HIV antisense transcripts occur naturally in people living with the virus. These findings do not constitute an HIV cure. They reveal something potentially more consequential: another biological mechanism that scientists may eventually learn to manipulate. The larger intelligence is about where medicine may be heading—from repeatedly controlling disease towards redesigning the conditions that allow disease to persist.